Microbial Study of Sublingual Immunotherapy Tablets in Patients With Allergic Rhinitis

Not yet recruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

December 20, 2024

Primary Completion Date

July 31, 2028

Study Completion Date

July 31, 2032

Conditions

Rhinitis, Allergic

Interventions

DRUG

ACARIZAX®️

ACARIZAX®️：The recommended dose for adults (18-65 years) is one freeze-dried tablet (12 SQ-HDM) daily, placed under the tongue.

Trial Locations (1)

The First Affiliated Hospital of Nanjing Medical University, Nanjing

All Listed Sponsors

lead

The First Affiliated Hospital with Nanjing Medical University

OTHER